Overview

Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy

Status:
Completed
Trial end date:
2017-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of Target-Controlled Infusion (TCI) of Remifentanil can deliver better conditions for performing bronchial fibroscopy with spontaneous ventilation (decrease the duration of cough) compared to the use of TCI of Propofol.
Phase:
Phase 4
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Propofol
Remifentanil